The Activities of Antimicrobials Against Stenotrophomonas maltophilia Isolates and Evaluation of Clinical Outcomes Among Treatment Regimens in Patients with Stenotrophomonas maltophilia Infections: A Retrospective Multicenter Cohort Study
Infection and Drug Resistance · 2023-08 · Volume 16 · 5173-5184
DOI: 10.2147/idr.s416678 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Infection and Drug Resistance, 2023-08. Verfasst von Patchrapa Boonmee und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacotherapy Thailand, Nonthaburi, Thailand. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
Stenotrophomonas maltophilia, a multidrug-resistant pathogen can cause hospital-acquired infections such as pneumonia, or bloodstream infection. S. maltophilia infection is associated with high mortality rates. This retrospective study examined the antimicrobial susceptibility profile of clinical S. maltophilia isolates and evaluated clinical outcomes, treatment regimens, and risk factors associated with 30-day mortality or treatment failure of S. maltophilia infections at three tertiary care hospitals in Central Thailand. Patients and Methods: The characteristics, microbiological data, and clinical treatment outcomes were derived from medical records obtained from three tertiary care hospitals in Central Thailand from January 2017 to October 2022. The primary outcomes were treatment failure and 30-day mortality. The antimicrobial susceptibility rates of trimethoprim-sulfamethoxazole (TMP-SMX), levofloxacin, and ceftazidime were determined by minimum inhibitory concentration (MIC), which were based on broth microdilution and clear zone diameters using the disk diffusion method. However, we also report the susceptibility of minocycline and tigecycline in some clinical S. maltophilia strains (n = 149) and determined by MIC with E-test method.
Results
The antimicrobial susceptibility rates to TMP-SMX, levofloxacin, and ceftazidime were 97.1%, 93%, and 55.3%, respectively. The treatment failure rate and 30-day mortality were 66.3% and 49%, respectively. Significant factors associated with treatment failure included APACHE II score ≥15 (OR 3.37, 95% confidence interval (CI) 1.46-7.76), polymicrobial infections (OR 3.20, 95% CI 1.35-7.55). The significant factors associated with reduced treatment failure was treatment with TMP-SMX-based regimen (OR 0.29, 95% CI 0.11-0.76). The 30-day mortality rate was associated with APACHE II score ≥15 (OR 3.27, 95% CI 1.45-7.39) and septic shock (OR 2.53, 95% CI 1.36-4.69).
Conclusion
The results indicate a high mortality rate for S. maltophilia infection. The predictive factors for an unfavourable outcome were severity of illness, septic shock, and non-use of TMP-SMX. Therefore, a TMP-SMX-based regimen is recommended for the treatment of S. maltophilia infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacotherapy Thailand, Nonthaburi, Thailand.
- Department of Pharmacy, Ratchaburi Hospital, Ratchaburi, Thailand.
- Division of Infectious Diseases, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
- Department of Medicine, Ratchaburi Hospital, Ratchaburi, Thailand.
- Pharmacy Unit, Nopparat Rajathanee Hospital, Bangkok, Thailand.
- Division of Microbiology, Phramongkutklao Hospital, Bangkok, Thailand.
ORCID-Profile: Worapong Nasomsong
Zitieren
APA
Boonmee, P., Nasomsong, W., Lorchirachoonkul, N., Pungcharoenkijkul, S., Juntanawiwat, P., Chaemchaeng, S., & Santimaleeworagun, W. (2023). The Activities of Antimicrobials Against Stenotrophomonas maltophilia Isolates and Evaluation of Clinical Outcomes Among Treatment Regimens in Patients with Stenotrophomonas maltophilia Infections: A Retrospective Multicenter Cohort Study. Infection and Drug Resistance, Volume 16, 5173-5184. https://doi.org/10.2147/idr.s416678
Vancouver
Boonmee P, Nasomsong W, Lorchirachoonkul N, Pungcharoenkijkul S, Juntanawiwat P, Chaemchaeng S, et al. The Activities of Antimicrobials Against Stenotrophomonas maltophilia Isolates and Evaluation of Clinical Outcomes Among Treatment Regimens in Patients with Stenotrophomonas maltophilia Infections: A Retrospective Multicenter Cohort Study. Infection and Drug Resistance. 2023;Volume 16:5173-5184. doi:10.2147/idr.s416678
BibTeX
@article{Boonmee2023,
author = {Boonmee, Patchrapa and Nasomsong, Worapong and Lorchirachoonkul, Narisorn and Pungcharoenkijkul, Supanun and Juntanawiwat, Piraporn and Chaemchaeng, Suphatthra and Santimaleeworagun, Wichai},
title = {The Activities of Antimicrobials Against Stenotrophomonas maltophilia Isolates and Evaluation of Clinical Outcomes Among Treatment Regimens in Patients with Stenotrophomonas maltophilia Infections: A Retrospective Multicenter Cohort Study},
journal = {Infection and Drug Resistance},
year = {2023},
volume = {Volume 16},
pages = {5173--5184},
doi = {10.2147/idr.s416678}
}
EUVIMED